Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Brignole C, Bensa V, Fonseca NA, Del Zotto G, Bruno S, Cruz AF, Malaguti F, Carlini B, Morandi F, Calarco E, Perri P, Moura V, Emionite L, Cilli M, De Leonardis F, Tondo A, Amoroso L, Conte M, Garaventa A, Sementa AR, Corrias MV, Ponzoni M, Moreira JN, Pastorino F. Brignole C, et al. Among authors: cilli m. J Exp Clin Cancer Res. 2021 Jun 2;40(1):180. doi: 10.1186/s13046-021-01993-9. J Exp Clin Cancer Res. 2021. PMID: 34078433 Free PMC article.
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
Brignole C, Marimpietri D, Pastorino F, Nico B, Di Paolo D, Cioni M, Piccardi F, Cilli M, Pezzolo A, Corrias MV, Pistoia V, Ribatti D, Pagnan G, Ponzoni M. Brignole C, et al. Among authors: cilli m. J Natl Cancer Inst. 2006 Aug 16;98(16):1142-57. doi: 10.1093/jnci/djj309. J Natl Cancer Inst. 2006. PMID: 16912267
Ligand-targeted liposomal therapies of neuroblastoma.
Pastorino F, Marimpietri D, Brignole C, Di Paolo D, Pagnan G, Daga A, Piccardi F, Cilli M, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: cilli m. Curr Med Chem. 2007;14(29):3070-8. doi: 10.2174/092986707782793916. Curr Med Chem. 2007. PMID: 18220743 Review.
A novel Bim-BH3-derived Bcl-XL inhibitor: biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity.
Ponassi R, Biasotti B, Tomati V, Bruno S, Poggi A, Malacarne D, Cimoli G, Salis A, Pozzi S, Miglino M, Damonte G, Cozzini P, Spyrakis F, Campanini B, Bagnasco L, Castagnino N, Tortolina L, Mumot A, Frassoni F, Daga A, Cilli M, Piccardi F, Monfardini I, Perugini M, Zoppoli G, D'Arrigo C, Pesenti R, Parodi S. Ponassi R, et al. Among authors: cilli m. Cell Cycle. 2008 Oct;7(20):3211-24. doi: 10.4161/cc.7.20.6830. Epub 2008 Oct 20. Cell Cycle. 2008. PMID: 18843207
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
Pastorino F, Di Paolo D, Piccardi F, Nico B, Ribatti D, Daga A, Baio G, Neumaier CE, Brignole C, Loi M, Marimpietri D, Pagnan G, Cilli M, Lepekhin EA, Garde SV, Longhi R, Corti A, Allen TM, Wu JJ, Ponzoni M. Pastorino F, et al. Among authors: cilli m. Clin Cancer Res. 2008 Nov 15;14(22):7320-9. doi: 10.1158/1078-0432.CCR-08-0804. Clin Cancer Res. 2008. PMID: 19010847
177 results